These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 21242064)

  • 1. The size of solid lipid nanoparticles: an interpretation from experimental design.
    Vitorino C; Carvalho FA; Almeida AJ; Sousa JJ; Pais AA
    Colloids Surf B Biointerfaces; 2011 May; 84(1):117-30. PubMed ID: 21242064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure.
    Kovacevic A; Savic S; Vuleta G; Müller RH; Keck CM
    Int J Pharm; 2011 Mar; 406(1-2):163-72. PubMed ID: 21219990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and optimization of solid lipid nanoparticles of amikacin by central composite design.
    Varshosaz J; Ghaffari S; Khoshayand MR; Atyabi F; Azarmi S; Kobarfard F
    J Liposome Res; 2010 Jun; 20(2):97-104. PubMed ID: 19621981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake.
    Tiwari R; Pathak K
    Int J Pharm; 2011 Aug; 415(1-2):232-43. PubMed ID: 21640809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles.
    Xie S; Wang S; Zhao B; Han C; Wang M; Zhou W
    Colloids Surf B Biointerfaces; 2008 Dec; 67(2):199-204. PubMed ID: 18829272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability.
    Varshosaz J; Tabbakhian M; Mohammadi MY
    J Liposome Res; 2010 Dec; 20(4):286-96. PubMed ID: 19958118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimental factorial design applied to mucoadhesive lipid nanoparticles via multiple emulsion process.
    Fangueiro JF; Andreani T; Egea MA; Garcia ML; Souto SB; Souto EB
    Colloids Surf B Biointerfaces; 2012 Dec; 100():84-9. PubMed ID: 22766285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multivariate design for the evaluation of lipid and surfactant composition effect for optimisation of lipid nanoparticles.
    Martins S; Tho I; Souto E; Ferreira D; Brandl M
    Eur J Pharm Sci; 2012 Apr; 45(5):613-23. PubMed ID: 22245538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation of surface-modified solid lipid nanoparticles (SLN): influence of lecithin and nonionic emulsifier.
    Schubert MA; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):77-86. PubMed ID: 16011893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quick synthesis of lipid-polymer hybrid nanoparticles with low polydispersity using a single-step sonication method.
    Fang RH; Aryal S; Hu CM; Zhang L
    Langmuir; 2010 Nov; 26(22):16958-62. PubMed ID: 20961057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.
    Küchler S; Herrmann W; Panek-Minkin G; Blaschke T; Zoschke C; Kramer KD; Bittl R; Schäfer-Korting M
    Int J Pharm; 2010 May; 390(2):225-33. PubMed ID: 20153414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and characterization of solid lipid nanoparticles loaded traditional Chinese medicine.
    Li Y; Dong L; Jia A; Chang X; Xue H
    Int J Biol Macromol; 2006 May; 38(3-5):296-9. PubMed ID: 16600362
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.